Dr. Prozialeck relocated to Chicago in 1991. He joined the faculty at
Midwestern University (then Chicago College of Osteopathic Medicine). In 1997 he was promoted to Chairman of the Department of Pharmacology at Midwestern University. In 1999 he was the inaugural recipient of the American Osteopathic Association's Korr Award for excellence in basic biomedical research. He was awarded the American Osteopathic Foundation Educator of the Year Award in 2010. He was named to Juniata College's Wall of fame and named a Distinguished Alumni. At Midwestern Prozialeck conducted research on the toxicity of cadmium. His research helped find early warning signs of kidney damage due to exposure to cadmium. In 2012 Prozialeck began being published about the controversial drug
kratom. He opposed of the
Drug Enforcement Administration's decision to classify the drug
Schedule 1, saying that it would make research on the drug extremely difficult. Researchers stated it would potentially escalate the
Opioid Crisis. He was interviewed in
Rolling Stone along with several other researchers. == Personal life ==